Engineering Biology Collaborative R&D: Round 3 supports business-led partnerships developing and scaling engineering biology products, processes and services to reduce adoption risks and drive UK growth.
Applications have closed; the opportunity’s status changed from Open to Closed.
Funder: UK Research and Innovation
Due Dates (Anticipated): November 2027 (Competition closing date)
Funding Amounts: Up to £8.5 million total; £750,000–£2.5 million eligible project costs; 12–36 months
Summary: Supports business-led collaborative industrial research to develop and scale engineering biology platforms, products and services.
Key Information: A UK-registered business must lead, with at least one UK-registered SME claiming funding and a named downstream end user involved.
Innovate UK, part of UK Research and Innovation (UKRI), supports collaborative R&D through UKRI’s Engineering Biology Programme. The competition aims to create new engineering biology products, processes and services, and de-risk adoption of technologies with high market potential. It supports purposeful engineering of biological systems to deliver functions unavailable naturally or inefficient through conventional approaches.
Projects must address a real UK commercialisation constraint, demonstrate a route to scale, and derive their primary innovation and competitive advantage from engineering biology. Translation, validation, scale-up, manufacturing, regulatory progression and commercial deployment are supported where directly enabled by that innovation. Priorities include well-defined scale-up constraints, market-led capability gaps, and growth and value creation in the UK.